Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease? (Q33607640)

28 July 2017

1 reference

title

Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease? (English)

1 reference

28 July 2017

1 reference

1 reference

Martínez M

1

1 reference

28 July 2017

Martínez N

series ordinal

2

1 reference

28 July 2017

Hernández AI

series ordinal

3

1 reference

28 July 2017

Ferrándiz ML

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

28 July 2017

1 reference

28 July 2017

64

1 reference

28 July 2017

15

1 reference

28 July 2017

1253-1257

1 reference

Oxygen free radicals and Parkinson's disease

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Oxidative stress and the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Parkinson's disease: a disorder due to nigral glutathione deficiency?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Mitochondrial complex I deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Mitochondrial complex I deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Origin and functional consequences of the complex I defect in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Use of N-acetylcysteine in clinical toxicology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Clinical pharmacokinetics of N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Lipoprotein(a) reduction by N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Protection from oxidation enhances the survival of cultured mesencephalic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

N-acetylcysteine protects against age-related increase in oxidized proteins in mouse synaptic mitochondria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

N-acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Protective Effect of N-Acetylcysteine in Tumor Necrosis Factor-α-Induced Apoptosis in U937 Cells: The Role of Mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Bcl-2 prevents nitric oxide-mediated apoptosis and poly(ADP-ribose) polymerase cleavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Reactive oxygen species participate in peroxynitrite-induced apoptosis in HL-60 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Metabolic studies with acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Restoration of cerebrovascular responsiveness to hyperventilation by the oxygen radical scavenger n-acetylcysteine following experimental traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Abnormalities of antioxidant metabolism in a case of Friedreich's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Glutathione distribution in natural products: absorption and tissue distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

Monoamine oxidase, dopamine and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

inferred from DOI database lookup

7 January 2021

based on heuristic

L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900472-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(98)00472-X

1 reference

28 July 2017

1 reference